Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
CLOUDBREAK
Fourth Extension - Granted
Show more
Class 1: Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits composed primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression in the fields of scientific, diagnostic and clinical research; reagent kits and beads with attached biomolecules, comprised primarily of oligonuc…
Class 5: Medical diagnostic reagents; reagent kits and beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical purposes and diagnostic medical purposes
Class 42: Providing diagnostic services for others in the fields of science and research related thereto; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings
Class 1 – ChemicalsClass 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 11 Feb 2023Application filedNew Application Entered
- 7 Sep 2023Assigned to an examining attorneyAssigned To Examiner
- 7 Sep 2023Office action issuedNon-Final Action Written
- 7 Dec 2023Response to office action filedTeas Response To Office Action Received
- 8 Jan 2024Approved for publicationApproved For Pub - Principal Register
- 13 Feb 2024Published for oppositionPublished For Opposition
- 13 Mar 2024Extension of time to oppose requestedExtension Of Time To Oppose Received
- 30 Jul 2024Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 22 Jan 2025Statement-of-use extension 1 grantedSou Extension 1 Granted
- 24 Jul 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 26 Jan 2026Statement-of-use extension 3 grantedSou Extension 3 Granted
All 36 events
| 2026-07-29 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-07-28 | Sou Teas Extension Received |
| 2026-07-28 | Sou Extension 4 Filed |
| 2026-07-28 | Sou Extension 4 Granted |
| 2026-01-27 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-01-26 | Sou Teas Extension Received |
| 2026-01-26 | Sou Extension 3 Filed |
| 2026-01-26 | Sou Extension 3 Granted |
| 2025-07-25 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-07-24 | Sou Teas Extension Received |
| 2025-07-24 | Sou Extension 2 Filed |
| 2025-07-24 | Sou Extension 2 Granted |
| 2025-03-04 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-01-22 | Sou Teas Extension Received |
| 2025-01-22 | Sou Extension 1 Filed |
| 2025-01-22 | Sou Extension 1 Granted |
| 2024-07-30 | Noa Mailed - Sou Required From Applicant |
| 2024-06-23 | Extension Of Time To Oppose Process - Terminated |
| 2024-03-13 | Extension Of Time To Oppose Received |
| 2024-02-13 | Published For Opposition |
| 2024-02-13 | Official Gazette Publication Confirmation E-Mailed |
| 2024-01-24 | Notification Of Notice Of Publication E-Mailed |
| 2024-01-08 | Examiners Amendment -Written |
| 2024-01-08 | Examiners Amendment E-Mailed |
| 2024-01-08 | Notification Of Examiners Amendment E-Mailed |
| 2024-01-08 | Examiner's Amendment Entered |
| 2024-01-08 | Approved For Pub - Principal Register |
| 2023-12-08 | Teas/Email Correspondence Entered |
| 2023-12-07 | Teas Response To Office Action Received |
| 2023-12-07 | Correspondence Received In Law Office |
| 2023-09-07 | Assigned To Examiner |
| 2023-09-07 | Non-Final Action Written |
| 2023-09-07 | Non-Final Action E-Mailed |
| 2023-09-07 | Notification Of Non-Final Action E-Mailed |
| 2023-02-28 | New Application Office Supplied Data Entered |
| 2023-02-11 | New Application Entered |
Goods & services by class
Class 1 Chemicals
Assays and reagents for use in genetic research; diagnostic reagents for scientific or research use; diagnostic reagents for clinical or medical laboratory use; reagents and reagent kits composed primarily of nucleic acids, naturally occurring or modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression in the fields of scientific, diagnostic and clinical research; reagent kits and beads with attached biomolecules, comprised primarily of oligonuc…
Class 5 Pharmaceuticals & supplements
Medical diagnostic reagents; reagent kits and beads with attached biomolecules, comprised primarily of oligonucleotides and other nucleic acids, natural and modified nucleotides, polypeptides, buffers, labels, and substrates, for clinical medical purposes and diagnostic medical purposes
Class 42 Technology & SaaS
Providing diagnostic services for others in the fields of science and research related thereto; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids from human beings
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 29 Jul 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.